Showing 1 to 20 of 634 approvalsPage 1 of 32
COSENTYX
Approved: May 17, 2024
novartis pharmaceuticals canada inc
DEXLANSOPRAZOLE
Approved: Jan 23, 2024
altius healthcare inc
DEXLANSOPRAZOLE
Approved: Jan 23, 2024
altius healthcare inc
UPLIZNA
Approved: Jun 18, 2024
Amgen Canada Inc
COUGH & CHEST CONGESTION EXTRA STRENGTH
Approved: Dec 30, 2024
crls
MUCUS & PHLEGM RELIEF WITH COUGH CONTROL EXTRA STRENGTH
Approved: Dec 30, 2024
crls
MUCUS & PHLEGM RELIEF EXTRA STRENGTH
Approved: Dec 30, 2024
crls
BRIGHT REVEAL SPF50+
Approved: Dec 28, 2024
l' oreal canada
CHLORAPREP SWABSTICKS
Approved: Dec 24, 2024
becton dickinson canada inc.
M-RIVAROXABAN
Approved: Dec 19, 2024
mantra pharma inc
M-RIVAROXABAN
Approved: Dec 19, 2024
mantra pharma inc
M-RIVAROXABAN
Approved: Dec 19, 2024
mantra pharma inc
M-RIVAROXABAN
Approved: Dec 19, 2024
mantra pharma inc
MIEBO
Approved: Dec 18, 2024
bausch & lomb inc
SITAGLIPTIN
Approved: Dec 17, 2024
sanis health inc
SITAGLIPTIN
Approved: Dec 17, 2024
sanis health inc
LURASIDONE
Approved: Dec 17, 2024
sanis health inc
LURASIDONE
Approved: Dec 17, 2024
sanis health inc
SITAGLIPTIN
Approved: Dec 17, 2024
sanis health inc
LURASIDONE
Approved: Dec 17, 2024
sanis health inc